SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

London-based Quant Network is set to revolutionise blockchain technology with the development of their blockchain operating system Overledger. The experienced team are determined to fulfil the original vision of the internet by creating an open trusted network for people, machines, and data to operate securely and safely.  Overledger -the first interoperable blockchain operating system that facilitates internet-scale development of decentralised, multi-chain applications. Overledger has the ability to unlock and distribute value and applications across current and future blockchains. It is an agnostic platform that connects the world's networks to blockchains and ensures you're not limited to any single a vendor or technology. Overledger is the only platform that facilitates the development of internet-scales development of decentralised, multi-chain applications.

Quant

Quants sharp rally is being linked by traders to its Oracle collaboration and reported role in bank tokenized-deposit and interoperability projects, with low supply and potential institutional demand adding to bullish speculation. Others question whether those partnerships will create meaningful demand for the QNT token, while the rapid gains have prompted volatile profit-taking and pullbacks.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

New 24-month HOPE-3 extension data showing slower upper-limb decline after patients switched from placebo to deramiocel has driven attention to Capricors Duchenne muscular dystrophy treatment. Traders view the findings as potentially strengthening the case ahead of the FDA decision, while others question whether the open-label results resolve the agencys earlier concerns about the trial analysis; approval and short-squeeze expectations remain speculative.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

ZBCNs sharp rally has sparked breakout and altcoin-momentum chatter, with traders speculating about Robinhood or BlackRock interest and pointing to Zebecs payroll and card utility; those rumored ties are not confirmed. Bullish calls for further gains are tempered by skepticism that the move could fade and complaints about the tokens weak past performance.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances higher full-year revenue outlook, reflecting stronger demand for Amtagvi and Proleukin, drove a sharp rally. Many traders are bullish and speculate that short covering amplified the move, while others warn of profit-taking or possible dilution and point to upcoming lung-cancer data as a further catalyst.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

Discussion centers on MoonLakes planned BLA submission for sonelokimab in hidradenitis suppurativa, with traders watching for filing news and debating whether it can restore confidence. That optimism is tempered by concerns about the share-price decline after dilution, managements commercialization strategy, and IZAR results that some investors say have not established best-in-class efficacy in psoriatic arthritis.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings selloff is fueling debate over competition from Kalshi and Polymarket, with bears concerned prediction markets could take wagering share and pressure margins. Bulls counter that DraftKings own Predictions platform is gaining volume and that state-level legal challenges to rivals could favor licensed sportsbooks; the impact remains uncertain.

GEOM maps the world's oil fields, mines, rare earths, and power plants, tracks what is and isn't tokenized, and cryptographically signs every dataset it publishes. Anyone can verify what we said and when. No account, no key, no permission. Sources include the WRI Global Power Plant Database and Global Energy Monitor (CC BY 4.0), attributed in full inside the app. Most of it already exists, spread across filings and terminals no one reads. GEOM gathers it and records where each figure came from.

GEOM

Traders are focused on GEOMs planned platform for tokenizing oil and mineral royalties, which they link to Greenland-related projects and companies including GLND and USFM; a platform demo or launch is anticipated, but its rollout and real-world adoption remain unverified. Bullish posts frame it as a new way to fund projects, while skeptics question the claims and warn about the tokens speculative, illiquid nature.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Deutsche Banks upgrade to Buy after Netflixs selloff, backed by its view that international engagement and valuation outweigh softer U.S. viewing, is driving attention. Traders are divided: some see value and a potential rebound, while others remain bearish over engagement trends, the content slate, and YouTube competition.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsofts Copilot overhauladding workplace-focused AI agents, coding tools, and deeper Office integrationhas renewed optimism about its AI strategy and drawn attention to a breakout in the shares. Traders are divided between seeing the features as a path to stronger adoption and questioning whether they will generate enough revenue to justify the rally.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is under pressure after an Edgewater Research note warned that growth and market-share gains may be nearing a ceiling, with securities class-action allegations adding to investor concerns. Bulls counter that AXON and e-commerce client data point to continued expansion, while skeptics remain focused on competition and slowing growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
